CXCR3 and its ligands interfere with the initial spread of osteosarcoma cells to the lung and stimulate the growth and expansion of metastatic foci at a later stage. Targeting CXCR3 specifically inhibits tumor metastasis without adversely affecting the anti-tumor host response. The gene discussed is CXCR3; the disease is neoplasm.